Publication Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021–2030 World Health Organization . 2021; Download PDF
Publication Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients. Hacker MA, Sales A, Duppre NC, et al. Scientific reports. 2021; 11 (1) : 1947. Download PDF
Publication A Systematic Review of the Importance of Chemoprophylaxis and Immunoprophylaxis in Subclinical Case of Leprosy that can Reduce the Incidence and the Transmission of Leprosy Mulianto N, Sari ADAP, Kariosentono H, et al. European Journal of Molecular & Clinical Medicine. 2020; 7 (11) : 709-715. Download PDF
Publication Leprosy post-exposure prophylaxis: innovation and precision public health. Moraes M, Duppre NC. The Lancet. Global health. 2021; 9 (1) : e8-e9. Download PDF
Publication Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020 WHO/Department of control of neglected tropical diseases . World Health Organization. 2020; Download PDF
Publication Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis World Health Organization . World Health Organization. 2020; Download PDF
Publication A comprehensive research agenda for zero leprosy Steinmann P, Dusenbury C, Addiss D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2020; Download PDF
Publication The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020; Download PDF
Publication Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy. Lenz SM, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583. Download PDF
